Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2011
Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantationRika Sakai, Heiwa Kanamori, Kenji Motohashi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2006
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients]Shigeki Motomura, Chizuko Hashimoto, Fumio Kodama, et al.Leukemia & Lymphoma|September 13, 2013
Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipientsTakayoshi Tachibana, Masatsugu Tanaka, Ayumi Numata, et al.Cancer Science|June 23, 2021
Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in JapanKoji Izutsu, Kiyoshi Ando, Momoko Nishikori, et al.Clinical Transplantation|March 25, 2014
Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in JapanAyumi Numata, Masatsugu Tanaka, Kenji Matsumoto, et al.Leukemia & Lymphoma|February 18, 2014
Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort studyWataru Yamamoto, Naoya Nakamura, Naoto Tomita, et al.Cancers|December 2, 2020
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 AlterationsSakura Tomita, Yara Yukie Kikuti, Joaquim Carreras, et al.International Journal of Hematology|August 23, 2024
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II studyKoji Izutsu, Kiyoshi Ando, Momoko Nishikori, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events]Fumio Kodama, Hiroshi Mohri, Shigeki Motomura, et al.Leukemia & Lymphoma|July 15, 2006
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphomaNaoto Tomita, Fumio Kodama, Rika Oshima, et al.Pageof 12